Skip to main content

Table 2 Clinical Global Impressions of Severity (CGI-S) Categorical Ratings at Baseline and Endpoint (Intention-to-Treat Population)

From: Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval

CGI-S Rating

Baseline (N = 67) n (%)

Endpoint (n = 67) n (%)

Normal

0

0

Borderline mentally ill

2 (3.0)

11 (16.4)

Mildly ill

32 (47.8)

31 (46.3)

Moderately ill

25 (37.3)

13 (19.4)

Markedly ill

8 (11.9)

11 (16.4)

Severely ill

0

1 (1.5)